Expression of EZH2 and H3K27me3 predicts tumor biology of urothelial carcinoma
Background: Enhancer of zeste homolog 2 (EZH2) is one of the major epigenetic modifiers involved in the transcriptional repression of target genes through trimethylation of H3K27 (lysine 27 residue of histone H3). Deregulated expression of both EZH2 and H3K27me3 has been implicated in the biological...
Saved in:
Main Authors: | Rasheeda Mohamedali, Suvradeep Mitra, Swarnendu Mandal, Prasant Nayak, Amit K. Adhya, Suvendu Purkait |
---|---|
Format: | Article |
Language: | English |
Published: |
Wolters Kluwer Medknow Publications
2023-07-01
|
Series: | Indian Journal of Pathology and Microbiology |
Subjects: | |
Online Access: | https://journals.lww.com/10.4103/ijpm.ijpm_1267_21 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Bisphenol B restrains rat leydig cell function via H3K27me3/H3K9me3 histone modifications
by: Jiayi He, et al.
Published: (2025-02-01) -
Case report: an unusual long-term evolution of a diffuse midline glioma, H3K27 altered
by: Michael Griessmair, et al.
Published: (2025-02-01) -
Sulfatase modifying factor 2 as a predictive biomarker for urothelial carcinoma
by: Wei-Ting Kuo, et al.
Published: (2025-02-01) -
CARBOXYLATO ADDUCTS AND DERIVATIVES CONTAINING SnR3 (R = Ph, Me) AND SnMe2 RESIDUES: SYNTHESIS, INFRARED AND MÖSSBAUER STUDIES
by: SEYDOU BASSENE, et al.
Published: (2019-09-01) -
3-Acetyldeoxynivalenol induces pyroptosis in leydig cells via METTL3-mediated N6-methyladenosine modification of NLRP3
by: Yangyun Wang, et al.
Published: (2025-01-01)